ECHA | 57th meeting of the Committee for Risk Assessment | May-June 2021 | Draft Agenda



The Provisional Draft Agenda 57th meeting of the Committee for Risk Assessment includes the following item(s):

Requests under Article 77(3)(c)

1) Classification for environmental toxicity of lead

Health based exposure limits at the workplace
1) Asbestos – final draft opinion

Harmonised classification and labelling (CLH)

CLH dossiers

1. Hazard classes for agreement without plenary debate (fasttrack)

- Reaction mass of 1-(2,3-epoxypropoxy)-2,2-bis ((2,3- epoxypropoxy)methyl) butane and 1-(2,3-epoxypropoxy)-2-((2,3- epoxypropoxy)methyl)-2-hydroxymethyl butane (EC: -; CAS: -) – germ cell mutagenicity, reproductive toxicity (discussed in the CLH WG)

- Sodium chlorate (EC: 231-887-4; CAS: 7775-09-9) – acute oral toxicity, hazardous to the aquatic environment (discussed in the CLH WG)

- Potassium chlorate (EC: 223-289-7; CAS: 3811-04-9) – acute oral and inhalation toxicity, hazardous to the aquatic environment (discussed in the CLH WG)

- Triethylamine (EC: 204-469-4; CAS: 121-44-8) – acute inhalation and dermal toxicity, seriour eye damage/eye irritation (discussed in the CLH WG)

- Di-n-butylamine (EC: 203-921-8; CAS: 111-92-2) – acute oral, dermal and inhalation toxicity, skin corrosion/irritation, serious eye damage/eye irritation, STOT SE (discussed in the CLH WG)

2. Hazard classes for agreement with plenary debate

1) Reaction mass of 1-(2,3-epoxypropoxy)-2,2-bis ((2,3- epoxypropoxy)methyl) butane and 1-(2,3-epoxypropoxy)-2-((2,3- epoxypropoxy)methyl)-2-hydroxymethyl butane (EC: -; CAS: -) – developmental toxicity

2) Triethylamine (EC: 204-469-4; CAS: 121-44-8) – acute oral toxicity

3) Difenoconazole (ISO); 1-({2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4- methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole; 3-chloro-4- [(2RS,4RS;2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3- dioxolan-2-yl]phenyl 4-chlorophenyl ether (EC 601-613-1; CAS 119446- 68-3)

4) 4-Nitrosomorpholine (EC: 627-564-6; CAS: 59-89-2)

5) N,N-dimethyl-p-toluidine (EC: 202-805-4; CAS: 99-97-8)

6) Metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin5(4H)-one; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio1,2,4-triazin-5-one (EC: 244-209-7; CAS: 21087-64-9)

7) [1] Lithium carbonate; [2] lithium chloride; [3] lithium hydroxide (EC: [1] 209-062-5; [2] 231-212-3; [3] 215-183-4; CAS: [1] 554-13-2; [2] 7447-41-8; [3] 1310-65-)

8) Nonylphenol, branched and linear, ethoxylated (with average molecular weight < 352 g/mol) [includes ortho-, meta-, para- isomers or any combination thereof] (EC: 500-315-8; 500-024-6; 500-045-0; 500- 209-1; 248-762-5; 243-816-4; 248-291-5; and others; CAS: 127087- 87-0; 9016-45-9; 26027-38-3; 68412-54-4; 27986-36-3; 20427-84-3; 27176-93-8; 1119449-38-5 and others)

9) Nonylphenol, branched and linear, ethoxylated (with 352 g/mol ≤ average molecular weight < 704 g/mol) [includes ortho-, meta-, paraisomers or any combination thereof] (EC: 230-770-5; 248-743-1; 247- 555-7; 248-293-6 and others; CAS: 127087-87-0; 9016-45-9; 7311-27- 5; 27942-27-4; 26264-02-8; 27177-05-5; 14409-72-4 and others)

10) Nonylphenol, branched and linear, ethoxylated (with 704 g/mol ≤ average molecular weight ≤ 1540 g/mol) [includes ortho-, meta-, paraisomers or any combination thereof] (EC: -; CAS: 127087-87-0; 9016- 45-9 and others)

Restriction Annex XV dossiers

1) Conformity check and key issues discussion

a) 1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo- [12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”™)

2) Opinion development

a) Undecafluorohexanoic acid (PFHxA), its salts and related substances – fourth draft opinion

b) Substances in single-use baby diapers – second draft opinion

c) Lead and its compounds in ammunition and fishing tackles – first draft opinion

Authorisation applications

1. Discussion on key issues

a) 5 applications for authorisation (chromium trioxide, chromic acid, dichromium tris(chromate))) from February 2021 submission window

Link to the Provisional Draft Agenda 57th meeting of the Committee for Risk Assessment


                   

Related News

Loading...